quinapril has been researched along with Cardiovascular Stroke in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (32.14) | 18.2507 |
| 2000's | 18 (64.29) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booij, HG; Damman, K; Rouleau, JL; van Gilst, WH; Warnica, JW; Westenbrink, BD | 1 |
| Dendorfer, A; Hauke, D; Krause, W; Schultheiss, HP; Siems, WE; Spillmann, F; Tschöpe, C; Walther, T | 1 |
| Bicket, DP | 1 |
| Hietakorpi, S; Magga, J; Penttilä, I; Peuhkurinen, K; Puhakka, M; Risteli, J; Uusimaa, P | 1 |
| Fike, D; Meyerrose, GE; Smith, J; Suarez, JA; Tsikouris, JP; Ziska, M | 1 |
| Meyerrose, GE; Simoni, JS; Suarez, JA; Tsikouris, JP; Ziska, M | 1 |
| Meyerrose, GE; Simoni, J; Suarez, JA; Sutthiwan, P; Tsikouris, JP; Ziska, M | 1 |
| Baer, JT; Berlin, JA; Kimmel, SE; Sauer, WH | 1 |
| Boomsma, F; Buikema, H; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Iwaniec, T; Potaczek, DP; Szczeklik, A; Undas, A | 1 |
| Buikema, H; Schoemaker, RG; van Gilst, WH; Westendorp, B | 1 |
| Boomsma, F; Buikema, H; de Zeeuw, D; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Brummel-Ziedins, KE; Bryniarski, L; Mann, KG; Potaczek, DP; Stobierska-Dzierzek, B; Szczeklik, A; Undas, A | 1 |
| Athyros, VG; Avramidis, MJ; Boudoulas, H; Kontopoulos, AG; Papadopoulos, GV; Papageorgiou, AA | 1 |
| Ertl, G; Frantz, S; Gaudron, P; Horn, M; Hu, K; Hugel, S; Neubauer, S; Schnackerz, K | 1 |
| Bonaduce, D; Marciano, F; Petretta, M | 1 |
| Kawamura, K; Kubota, J; Mori, T; Nishimura, H; Okabe, M; Ueyama, M | 1 |
| Anders, HJ; Ertl, G; Gaudron, P; Hu, K; Nahrendorf, M; Turschner, O; Weidemann, F | 1 |
| Leenen, FH; Skarda, V; White, R; Yuan, B | 1 |
| Hori, M; Hoshida, S; Kawahara, K; Kuzuya, T; Yamashita, N | 1 |
| Athyros, VG; Boudoulas, H; Kontopoulos, AG; Papageorgiou, AA | 1 |
| Hikosaka, M; Iwasaka, T; Kawamura, A; Mimura, J; Motohiro, M; Sugiura, T; Sumimoto, T; Yuasa, F; Yuyama, R | 1 |
| Francis, GS; Gassler, JP | 1 |
| Cernacek, P; Nguyen, QT; Picard, P; Qi, XL; Rouleau, JL; Sia, YT; Sirois, M; Stewart, DJ; Wei, G | 1 |
| Dienesch, C; Horn, M; Hügel, S; Neubauer, S; Remkes, H | 1 |
| Liu, P; Qu, R; Rouleau, JL; Sirois, MG; Wei, GC | 1 |
| Liu, P; Qu, R; Roulea, JL; Siroi, MG; We, GC | 1 |
1 review(s) available for quinapril and Cardiovascular Stroke
| Article | Year |
|---|---|
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
8 trial(s) available for quinapril and Cardiovascular Stroke
| Article | Year |
|---|---|
β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Double-Blind Method; Female; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Quinapril; Risk Factors; Stroke; Tetrahydroisoquinolines | 2015 |
Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction?
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Permeability; Plasminogen Activator Inhibitor 1; Quinapril; Tetrahydroisoquinolines; Tissue Plasminogen Activator | 2004 |
Exploring the effects of ACE inhibitor tissue penetration on vascular inflammation following acute myocardial infarction.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; C-Reactive Protein; Chi-Square Distribution; Coronary Vessels; Enalapril; Female; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Quinapril; Tetrahydroisoquinolines | 2004 |
Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Vessels; Enalapril; Endothelin-1; Humans; Middle Aged; Myocardial Infarction; Nitric Oxide; Quinapril; Tetrahydroisoquinolines | 2004 |
Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Atorvastatin; Blood Coagulation; Blood Coagulation Factors; Coronary Artery Disease; Double-Blind Method; Evaluation Studies as Topic; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Pyrroles; Quinapril; Risk Factors; Stroke; Tetrahydroisoquinolines; Time Factors | 2006 |
Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Female; Heart Rate; Humans; Isoquinolines; Male; Metoprolol; Middle Aged; Myocardial Infarction; Prospective Studies; Quinapril; Tetrahydroisoquinolines | 1996 |
Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Circadian Rhythm; Female; Heart Rate; Hemodynamics; Humans; Isoquinolines; Male; Metoprolol; Middle Aged; Myocardial Infarction; Parasympathetic Nervous System; Prospective Studies; Quinapril; Sympathetic Nervous System; Tetrahydroisoquinolines | 1999 |
Effect of angiotensin-converting enzyme inhibitor on cardiopulmonary baroreflex sensitivity in patients with acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Baroreflex; Blood Flow Velocity; Central Venous Pressure; Female; Forearm; Humans; Isoquinolines; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Quinapril; Renin; Sympathetic Nervous System; Tetrahydroisoquinolines; Vascular Resistance | 2000 |
19 other study(ies) available for quinapril and Cardiovascular Stroke
| Article | Year |
|---|---|
AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Hemodynamics; Irbesartan; Isoquinolines; Male; Myocardial Infarction; Myocardium; Neprilysin; Quinapril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrahydroisoquinolines; Tetrazoles | 2002 |
Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Arrhythmias, Cardiac; Biomarkers; C-Reactive Protein; Collagen; Creatine Kinase; Creatine Kinase, MB Form; Electrocardiography; Enalapril; Female; Finland; Humans; Interleukin-6; Isoenzymes; Male; Myocardial Infarction; Peptide Fragments; Procollagen; Quinapril; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Trinitrotoluene; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left | 2003 |
Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Quinapril; Tetrahydroisoquinolines; Treatment Outcome; United States | 2004 |
Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium, Vascular; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Substance Withdrawal Syndrome; Tetrahydroisoquinolines | 2006 |
The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease.
Topics: Alleles; Angiography; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Blood Pressure; Coronary Artery Disease; Fibrin Fibrinogen Degradation Products; Genotype; Hemostasis; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Pyrroles; Quinapril; Risk; Tetrahydroisoquinolines; Time Factors | 2005 |
Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction.
Topics: Acetylcholine; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Factors; Endothelium, Vascular; Male; Myocardial Infarction; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Vasodilation | 2005 |
Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Drug Therapy, Combination; Follow-Up Studies; Hydrochlorothiazide; Male; Myocardial Infarction; Quinapril; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Pressure | 2005 |
[The heart of the matter in cardiovascular therapy. ACE-inhibition with Quinapril: hypertension, myocardial infarction, cardiac insufficiency].
Topics: Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Isoquinolines; Myocardial Infarction; Quinapril; Tetrahydroisoquinolines | 1993 |
Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Energy Metabolism; Hypoxia; Isoquinolines; Magnetic Resonance Spectroscopy; Myocardial Infarction; Phosphates; Phosphocreatine; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Dysfunction, Left | 1996 |
Converting enzyme inhibition, heart rate variability, and myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Heart Rate; Humans; Isoquinolines; Metoprolol; Myocardial Infarction; Quinapril; Tetrahydroisoquinolines | 1996 |
Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Catheterization; Cardiac Output; Heart; Heart Ventricles; Hypertension; Isoquinolines; Kidney; Male; Myocardial Infarction; Myocardium; Organ Size; Quinapril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tetrahydroisoquinolines | 1998 |
Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Isoquinolines; Losartan; Male; Myocardial Infarction; Organ Size; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines | 1998 |
Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Heart Ventricles; Isoquinolines; Male; Myocardial Infarction; Myocardium; Nephrectomy; Quinapril; Rats; Rats, Wistar; Renin; Tetrahydroisoquinolines | 1999 |
Amelioration by quinapril of myocardial infarction induced by coronary occlusion/reperfusion in a rabbit model of atherosclerosis: possible mechanisms.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arterial Occlusive Diseases; Coronary Artery Disease; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Isoquinolines; Leukocytes; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; P-Selectin; Peroxidase; Quinapril; Rabbits; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrahydroisoquinolines; Ventricular Fibrillation | 1999 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Myocardial contractile responsiveness to endothelin-1 in the post-infarction rat model of heart failure: effects of chronic quinapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Binding, Competitive; Body Weight; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Heart Failure; Hemodynamics; Isoquinolines; Kinetics; Male; Muscles; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oligopeptides; Organ Culture Techniques; Organ Size; Papillary Muscles; Peptides, Cyclic; Piperidines; Protein Binding; Quinapril; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydroisoquinolines; Time Factors; Vasoconstrictor Agents; Viper Venoms | 2001 |
Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatine Kinase; Disease Models, Animal; Energy Metabolism; Heart Failure; Isoquinolines; Magnetic Resonance Spectroscopy; Myocardial Infarction; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Remodeling | 2001 |
Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Isoquinolines; Male; Myocardial Infarction; Myocardium; Quinapril; Rats; Rats, Wistar; Survival Rate; Tetrahydroisoquinolines; Ventricular Remodeling | 2002 |
Effects of quinapril on myocardial function, ventricular remodeling and cardiac cytokine expression in congestive heart failure in the rat.
Topics: Animals; Cytokines; Heart Failure; Hemodynamics; Isoquinolines; Male; Myocardial Infarction; Quinapril; Rats; Rats, Wistar; Tetrahydroisoquinolines; Ventricular Remodeling | 2002 |